Cargando…
Assessment of the Novel, Practical, and Prognosis-Relevant TNM Staging System for Stage I-III Cutaneous Melanoma
BACKGROUND: The clinical TNM staging system does not differ between the 7(th) and 8(th) editions of the American Joint Committee on Cancer (AJCC) staging manual. A more practical TNM staging system for patients with stage I-III cutaneous melanoma are needed. METHODS: Data were accessed from the Surv...
Autores principales: | Hu, Di, Liu, Zeming, Chen, Sichao, Huang, Yihui, Zeng, Wen, Wei, Wei, Zhang, Chao, Zhou, Ling, Chen, Danyang, Wu, Yiping, Guo, Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9104117/ https://www.ncbi.nlm.nih.gov/pubmed/35574383 http://dx.doi.org/10.3389/fonc.2022.738298 |
Ejemplares similares
-
Patients Aged ≥55 Years With Stage T1-2N1M1 Differentiated Thyroid Cancer Should Be Downstaged in the Eighth Edition AJCC/TNM Cancer Staging System
por: Liu, Zeming, et al.
Publicado: (2019) -
Is a simplified TNM staging system more clinically relevant than the American Joint Committee on Cancer system for the follicular variant of papillary thyroid cancer?
por: Hu, Di, et al.
Publicado: (2020) -
Rethinking the 8th AJCC System: Is It Suitable for Patients Aged <55 Years With Stage T4N1M0 Follicular Variant of Papillary Thyroid Carcinoma to Be Placed in Stage I?
por: Long, Wei, et al.
Publicado: (2020) -
Integrating additional factors into the TNM staging for cutaneous melanoma by machine learning
por: Yang, Charles Q., et al.
Publicado: (2021) -
Synergistic effects of histologic subtype, T-stage, and M-stage in the prognosis of differentiated thyroid cancer: a retrospective observational study
por: Zhou, Ling, et al.
Publicado: (2020)